Kılıçkap, S. Et Al. 2018. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey. IASLC 19th World Conference on Lung Cancer 20181 , (Toronto, Canada).

Kılıçkap, S., Öztürk, A., Karadurmuş, N., Korkmaz, T., Yumuk Perran, F., Çiçin, İ., ... Paydaş, S.(2018). Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey . IASLC 19th World Conference on Lung Cancer 20181, Toronto, Canada

Kılıçkap, Saadettin Et Al. "Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey," IASLC 19th World Conference on Lung Cancer 20181, Toronto, Canada, 2018

Kılıçkap, Saadettin Et Al. "Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey." IASLC 19th World Conference on Lung Cancer 20181 , Toronto, Canada, 2018

Kılıçkap, S. Et Al. (2018) . "Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey." IASLC 19th World Conference on Lung Cancer 20181 , Toronto, Canada.

@conferencepaper{conferencepaper, author={Saadettin Kılıçkap Et Al. }, title={Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey}, congress name={IASLC 19th World Conference on Lung Cancer 20181}, city={Toronto}, country={Canada}, year={2018}}